Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

CP Kelco UK Ltd
Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400
Contact CP Kelco UK Ltd
Website

 Latest Content from PMHub 

What if you could shape your next campaign messaging with the media before launch?

Press Releases | November 4, 2024 | EatMoreFruit

Sometimes you just can’t see the wood from the trees. Teams gets so focussed on the technology or treatment you’re selling that the inevitable outcome is a feature-peddling monologue where...

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

White Papers and Resources | November 1, 2024 | Innovative Trials

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

White Papers and Resources | November 1, 2024 | Innovative Trials

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

White Papers and Resources | November 1, 2024 | Innovative Trials

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

Recognizing C diff Awareness Month in 2024

Press Releases | October 31, 2024 | Medscape Education

Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every...

AI-Driven Platforms Enhance Drug Discovery Collaborations

Press Releases | October 31, 2024 | Springer Nature

Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates.

Medscape Education presenting at the 17th Annual European CME Forum

Press Releases | October 31, 2024 | Medscape Education

With a commitment to advancing the field of continuing medical education, the Medscape team will be travelling to Madrid for the 17th Annual European CME Forum and bringing with them...

How Innovative Trials are making a difference to clinical trials in the US

White Papers and Resources | October 30, 2024 | Innovative Trials

Eloise Moffett, Innovative Trials’ Vice President of Commercial, reflects on how the company’s growing presence in the US is transforming client relationships and its ability to provide the best patient-centric...

Pharma-exclusive Webinar: Next-gen Virtual Tools for Education & Learning in the Life Sciences

Press Releases | October 29, 2024 | Impetus Digital

Unlock the potential of next-gen virtual tools in our upcoming webinar. From AI simulations to interactive AR booths, learn how to effectively apply these technologies in life sciences education and...

Innovative Trials named a top UK women-powered company in clinical research by J.P. Morgan

Press Releases | October 29, 2024 | Innovative Trials

Innovative Trials has been named the second-fastest-growing, women-powered UK company in clinical research and ranks among the top 200 women-powered businesses in the UK!